Pill Testing to Stay: NSW Trial Success

New South Wales has committed $4.3 million to continue its drug-checking program at music festivals for the next four years. This initiative will see drug checks rolled out at up to 15 music festivals annually, commencing in October. The program, delivered by NSW Health and industry partners, follows a successful trial that concluded in February 2026.

The trial, which ran from March 2025 to February 2026, demonstrated a notable decrease in drug-related hospitalizations, falling from 3.6 events per festival day to 2.3 events per day. The evaluation indicated that festivals targeting younger demographics and those in regional areas were most likely to benefit. This harm reduction service was accessed by over 85% of people under 30.

Health Minister Ryan Park emphasized that while illicit drugs remain illegal, the drug-checking services are designed to save lives by reducing harms associated with drug use. During the trial, 8% of tested samples contained unexpected substances, and 4% of MDMA capsules were high-dose. Almost 22% of participants received free take-home naloxone.

Advocates, including Jennie Ross-King whose daughter died from an MDMA overdose, welcomed the decision, stressing the importance of harm reduction. The program's integration with public early warning systems proved impactful, informing many NSW Health drug warnings. Close to 97% of users reported increased confidence in managing drug-related harms.